Skip to Content

Safinamide use while Breastfeeding

Drugs containing Safinamide: Xadago

Medically reviewed by Drugs.com. Last updated on Oct 18, 2020.

Safinamide Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the use of safinamide during breastfeeding. Because of liver toxicity in nursing rat pups, the manufacturer recommends that the drug not be used in nursing mothers. Alternate agents are preferred.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Selegiline

Substance Identification

Substance Name

Safinamide

CAS Registry Number

133865-89-1

Drug Class

  • Breastfeeding
  • Lactation
  • Antiparkinson Agents
  • Monoamine Oxidase Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.